Ticiana Leal

19PUBLICATIONS
115CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Aug 18, 2026
Longitudinal Phenotyping of Circulating Tumor Cells using a Scalable Deep Learning Framework.

|Jul 08, 2026
Real-World Implementation of Tarlatamab-Dlle Therapy for Patients With Extensive-Stage Small Cell Lung Cancer and Other High-Grade Neuroendocrine Neoplasms.

|Jun 17, 2025
Randomized phase II clinical trial of cisplatin/carboplatin and etoposide (PE) alone or in combination with nivolumab as frontline therapy for extensive-stage small cell lung cancer (ES-SCLC): ECOG-ACRIN EA5161.

Ticiana A Leal, Yating Wang, Afshin Dowlati

|Sep 20, 2024
Real-World Outcomes of First-Line Treatment With Anti-PD(L)1-Based Combination Therapy for Nonsquamous Metastatic Non-Small Cell Lung Cancer: A Multiregional Chart Review in Europe, Japan, and the United States.

Stephen V Liu, Anandaroop Dasgupta, Dominick Latremouille-Viau

|Sep 19, 2024
Inhibition of hTERT/telomerase/telomere mediates therapeutic efficacy of osimertinib in EGFR mutant lung cancer.

Zhen Chen, Karin A Vallega, Dongsheng Wang

|Mar 14, 2024
Real-World Treatment Patterns and Clinical Outcomes After Platinum-Doublet Chemotherapy and Immunotherapy in Metastatic Non-Small Cell Lung Cancer: A Multiregional Chart Review in the United States, Europe, and Japan.

Ticiana A Leal, Anandaroop Dasgupta, Dominick Latremouille-Viau

Pageof 4

Frequent Collaborators

6 joint publications

Suresh S Ramalingam

4 joint publications

Jennifer W Carlisle

3 joint publications

Stephen V Liu

3 joint publications

Martin Reck